Clinical Outcomes, Compliance and Effectiveness of Switching From Infliximab or Etanercept to Adalimumab in Patients With Active Rheumatoid Arthritis (RA). A Multicenter Post-Marketing Observational Study in Routine Clinical Use
Clinical trial NCT01083160 · TERMINATED
Trial details
- NCT number
- NCT01083160
- Sponsor
- Abbott
- Status
- TERMINATED
- Study type
- OBSERVATIONAL
- Start date
- 2008-04-01
- Primary completion
- 2010-11-01
- Enrollment
- 82
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.